院内心脏骤停的合并症负担与生存趋势:一项瑞典队列研究
该研究纳入2007年1月1日至2015年12月31日期间在Karolinska大学医院发生院内心脏骤停(IHCA)的1373例≥18岁患者,从电子病历获取ACCI及30天生存数据。ACCI中位4分(IQR 3-6),各年间几乎不变;376例(27%)存活至少30天。按ACCI分层后,低ACCI(0-2分)患者2013-2015年较2007-2009年30天生存调整OR 2.61(95%CI 1.38-4.94),中度ACCI(3-5分)调整OR 1.87(95%CI 1.14-3.09)。作者认为这提示合并症负担稳定而低至中度合并症患者生存改善。
要点
- 1373例IHCA患者中376例(27%)存活至少30天;ACCI中位4分(IQR 3-6),研究期间几乎不变。
- 低ACCI(0-2分)患者2013-2015年较2007-2009年30天生存调整OR 2.61(95%CI 1.38-4.94)。
- 中度ACCI(3-5分)患者2013-2015年较2007-2009年30天生存调整OR 1.87(95%CI 1.14-3.09)。
- 调整因素包括医院地点、性别、初始心律、心电监护、是否目击及IHCA发生地点。
适用人群与场景
- 2007年1月1日至2015年12月31日期间在Karolinska大学医院发生IHCA的≥18岁患者。
诊断标准与关键阈值
- ACCI按入院时病历中的ICD-10编码评估,分为低0-2分、中度3-5分、高6-8分、极高≥9分。
研究设计与关键结果
- 研究类型为队列研究,共纳入1373例IHCA患者,376例(27%)存活至少30天。
- ACCI中位4分(IQR 3-6),各年间几乎不变。
- 低ACCI(0-2分)患者2013-2015年较2007-2009年30天生存调整OR 2.61(95%CI 1.38-4.94)。
- 中度ACCI(3-5分)患者2013-2015年较2007-2009年30天生存调整OR 1.87(95%CI 1.14-3.09)。
- 调整因素包括医院地点、性别、初始心律、心电监护、是否目击及IHCA发生地点。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该队列研究揭示IHCA患者合并症负担随时间几乎不变,并强调低至中度ACCI患者30天生存从2007-2009年到2013-2015年几乎翻倍。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Co-morbidities affect survival after in-hospital cardiac arrests (IHCA). The risk population for IHCA, i.e. the hospitalised patients, have a doubled increase in co-morbidities over time. A similar increase in co-morbidities among IHCAs might explain the relatively poor survival ratios despite improved care.
AIM: To assess changes in the burden of baseline age-adjusted Charlson co-morbidity index (ACCI) scores among IHCAs as well as to assess its impact on survival in three time periods.
MATERIAL AND METHODS: All patients ≥18 years suffering an IHCA at Karolinska University Hospital between 1st January 2007 and 31st December 2015 were included. Data regarding the IHCA, patient characteristics, ACCI and 30 day survival were obtained from electronic patient records. Parameters included in ACCI were assessed as ICD-10 codes in the medical file at admission to hospital. The median ACCI with interquartile range (IQR) was presented per year. ACCI was categorised into low 0-2points, moderate 3-5points, high 6-8 points and very high ≥9 points. Differences in survival between 2007 and 2009 and 2010-2012 as well as 2013-2015 were stratified per ACCI category and assessed with adjusted logistic regression models and presented as Odds Ratios with 95% Confidence Intervals (OR, 95% CI). Adjustments included hospital site, sex, first rhythm, ECG-surveillance, witnessed or not, and location of the IHCA.
RESULTS: In all, 1373 patients suffered an IHCA, of whom 376 (27%) survived at least 30 days. The ACCI remained almost constant over time at median 4, IQR 3-6. Patients with low or moderate ACCI more than doubled their survival in 2013-2015 compared to 2007-2009 (adjusted OR 2.61 95% CI1.38-4.94 and OR 1.87 95% CI 1.14-3.09 respectively).
CONCLUSION: This cohort study illuminates an almost constant burden of co-morbidities over time among patients suffering an IHCA. Further, the study highlights that 30-day survival has almost doubled from 2007 to 2009 to 2013-2015 among those with low to moderate AccI.
参考来源
- Hjalmarsson P, Memar M, Geara SJ, et al. Trends in co-morbidities and survival for in-hospital cardiac arrest -A Swedish cohort study. Resuscitation. 2017. PMID: 29288015. doi:10.1016/j.resuscitation.2017.12.025
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。